Keyphrases
Acute Myeloid Leukemia
57%
Subfoveal
50%
Tumor
50%
Orbital Lymphoma
50%
In Cancer
50%
Phase II Study
50%
Anti-Hu Antibody
50%
Cancer Patients
50%
Primary Radiotherapy
50%
Myelodysplastic Syndrome
50%
Hepatosplenic T-cell Lymphoma
50%
Radiation Therapy
50%
HIV Infection
50%
Ovarian Cancer
50%
Continuous Infusion
50%
Thrombosis
50%
Topotecan
50%
Oxaliplatin
50%
Visual Recovery
50%
Previously Treated
50%
Unfractionated Heparin
50%
Failure Pattern
50%
Dasatinib
50%
Pancytopenia
50%
Sensorimotor Polyneuropathy
50%
Extraskeletal Myxoid Chondrosarcoma
50%
Supraclavicular
50%
Maintenance Dose
50%
Chronic Myeloid Leukemia
50%
Aplastic Anemia
50%
External Beam Radiotherapy
33%
Leukemia
33%
Antineural Antibodies
33%
Infiltration
29%
Cytopenia
29%
Continuous Intravenous Infusion
27%
Thromboembolism
25%
Cancer-associated Venous Thromboembolism
25%
Malignancy
25%
Phase II Trial
22%
Overall Survival Rate
22%
Topoisomerase Inhibitors
20%
Cytarabine
16%
Consolidation Therapy
16%
Anti-Hu Syndrome
16%
Limb-girdle
16%
Vision Threatening
16%
External Beam Radiation
16%
Induction Chemotherapy
16%
Left Eye
16%
Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
60%
Disease
50%
Topotecan
50%
Malignant Neoplasm
50%
Acute Myeloid Leukemia
50%
External Beam Radiotherapy
50%
Orbital Lymphoma
50%
Hu Antibody
50%
Hepatosplenic T-Cell Lymphoma
50%
Ovarian Cancer
50%
Continuous Infusion
50%
Oxaliplatin
50%
Thrombosis
50%
Dasatinib
50%
Polyneuropathy
50%
Pancytopenia
50%
Chondrosarcoma
50%
Aplastic Anemia
50%
Chronic Myelogenous Leukemia
50%
Chronic Myelogenous Leukemia
33%
Chemotherapy
33%
Cancer
33%
Metastatic Carcinoma
33%
Intravenous Drug Administration
30%
Cytopenia
29%
Recurrent Disease
26%
Venous Thromboembolism
25%
Overall Survival
22%
Survival Rate
22%
Topoisomerase
20%
Low Drug Dose
16%
Leukemia
16%
Cytarabine
16%
Thromboembolism
16%
Induction Chemotherapy
16%
Visual Impairment
16%
Intraocular Tumor
16%
Limb
16%
Paraneoplastic Syndrome
16%
Connective Tissue Cancer
16%
Peripheral T-Cell Lymphoma
12%
Hepatosplenomegaly
12%
T Lymphocyte Receptor
12%
Lymphoma
12%
Neutropenia
10%
Thrombocytopenia
10%
Primary Peritoneal Cancer
10%
Lacrimal Gland
10%
Fallopian Tube
10%
